Long COVID: An inevitable sequela of SARS-CoV-2 infection

• Published in: Journal of microbiology, immunology and infection Vol. 56; no. 1; pp. 1 - 9
• Main Authors: Lai, Chih-Cheng, Hsu, Chi-Kuei, Yen, Muh-Yong, Lee, Ping-Ing, Ko, Wen-Chien, Hsueh, Po-Ren
• Format: Journal Article
• Language: English
• Published: England Elsevier B.V 01.02.2023; Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC; Elsevier
• Subjects: COVID-19; COVID-19 - complications; Disease Progression; Humans; Long COVID; Lung; Post-acute COVID; Post-Acute COVID-19 Syndrome; Quality of Life; Review; SARS-CoV-2; Vaccine; COVID-19; SARS-CoV-2; Post-acute COVID; Vaccine; Long COVID

At present, there are more than 560 million confirmed cases of the coronavirus disease 2019 (COVID-19) worldwide. Although more than 98% of patients with severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection can survive acute COVID, a significant portion of survivors can develop res...